BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21851448)

  • 1. New drugs for Alzheimer's disease in Japan.
    Takeda M; Tanaka T; Okochi M
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):399-404. PubMed ID: 21851448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UK government guidance on Alzheimer's drugs postponed.
    O'Neill MF
    Drug Discov Today; 2005 Sep; 10(17):1132. PubMed ID: 16182201
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
    Aisen PS
    J Am Acad Nurse Pract; 2005 Mar; Suppl():5-7. PubMed ID: 16033023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective pharmacological management of Alzheimer's disease.
    Atri A
    Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: will advances made in the past turn the tide?
    Semla TP
    Ann Pharmacother; 2007 Sep; 41(9):1494-6. PubMed ID: 17666576
    [No Abstract]   [Full Text] [Related]  

  • 8. [Advances in Alzheimer's disease treatment].
    Nourhashémi F
    Rev Med Interne; 2006 Aug; 27(8):585-7. PubMed ID: 16782240
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discontinuing Alzheimer's disease drug therapy: why, when, and how.
    Crutchfield D
    Director; 2008; 16(1):19-21. PubMed ID: 19343870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Summaries for patients. Drug treatment for patients with dementia: American College of Physicians and American Academy of Family Physicians recommendations.
    Ann Intern Med; 2008 Mar; 148(5):I41. PubMed ID: 18316749
    [No Abstract]   [Full Text] [Related]  

  • 12. Alzheimer disease and its management: a review.
    Samanta MK; Wilson B; Santhi K; Kumar KP; Suresh B
    Am J Ther; 2006; 13(6):516-26. PubMed ID: 17122533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAFP and ACP release guideline on dementia treatment.
    Graham L
    Am Fam Physician; 2008 Apr; 77(8):1173-5. PubMed ID: 18481566
    [No Abstract]   [Full Text] [Related]  

  • 14. Dementia.
    Warner J; Butler R; Arya P
    Clin Evid; 2004 Dec; (12):1361-90. PubMed ID: 15865724
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
    Prasher VP
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
    Blais L; Kettani FZ; Perreault S; Leroux JC; Forget A; Kergoat MJ
    J Am Geriatr Soc; 2009 Feb; 57(2):366-8. PubMed ID: 19207161
    [No Abstract]   [Full Text] [Related]  

  • 19. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
    Formiga F; Fort I; Robles MJ; Rodriguez D; Regalado P
    Dement Geriatr Cogn Disord; 2010; 29(3):198-203. PubMed ID: 20332637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.